← All Traws Pharma, INC filings

Traws Pharma, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
TRAW
Traws Pharma, INC
SCHEDULE: OrbiMed Increases Stake in Traws Pharma via Private Placement
OrbiMed Advisors and OrbiMed Capital GP VIII have disclosed an increased beneficial ownership stake in Traws Pharma, Inc. following a recent private placement.
NASDAQ
TRAW
Traws Pharma, INC
SCHEDULE 13D/A: OrbiMed Advisors Increases Stake in Traws Pharma to 19.9% Following Recent Offering
OrbiMed Advisors and OrbiMed Capital GP VIII LLC have increased their beneficial ownership in Traws Pharma, Inc. to 19.9% of outstanding common stock following the company's recent Class A and Class B Unit offering.